Mar 16th, 2015

Is Amgen’s New Heart Drug a Potential Blockbuster?

Amgen has a new heart drug that is leading a pack of potentially new blockbuster medicines that can provide a big boost to revenues in the pharmaceutical industry. Bloomberg Intelligence’s Senior Biotech Analyst Asthika Goonewardene reports on “Bloomberg Surveillance.” (Source: Bloomberg)